1.Altered Brain Activation in Ventral Frontal-Striatal Regions Following a 16-week Pharmacotherapy in Unmedicated Obsessive-Compulsive Disorder.
Ji Yeon HAN ; Do Hyung KANG ; Bon Mi GU ; Wi Hoon JUNG ; Jung Seok CHOI ; Chi Hoon CHOI ; Joon Hwan JANG ; Jun Soo KWON
Journal of Korean Medical Science 2011;26(5):665-674
Recent studies have reported that cognitive inflexibility associated with impairments in a frontal-striatal circuit and parietal region is a core cognitive deficit of obsessive-compulsive disorder (OCD). However, few studies have examined progressive changes in these regions following clinical improvement in obsessive-compulsive symptoms. To determine if treatment changes the aberrant activation pattern associated with task switching in OCD, we examined the activation patterns in brain areas after treatment. The study was conducted on 10 unmedicated OCD patients and 20 matched controls using event-related functional magnetic resonance imaging. Treatment improved the clinical symptoms measured by the Yale-Brown Obsessive Compulsive Scale and behavioral flexibility indicated by the switching cost. At baseline, OCD showed significantly less activation in the dorsal and ventral frontal-striatal circuit and parietal regions under the task-switch minus task-repeat condition compared with controls. After treatment, the neural responses in the ventral frontal-striatal circuit in OCD were partially normalized, whereas the activation deficit in dorsal frontoparietal regions that mediate shifting attention or behavioral flexibility persisted. It is suggested that altered brain activation in ventral frontal-striatal regions in OCD patients is associated with their cognitive flexibility and changes in these regions may underlie the pathophysiology of OCD.
Adult
;
Basal Ganglia/*metabolism
;
Behavioral Symptoms/drug therapy
;
Female
;
Frontal Lobe/*drug effects/physiopathology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Obsessive-Compulsive Disorder/*drug therapy/physiopathology
;
Parietal Lobe/*drug effects/physiopathology
2.Pharmacotherapy and Regional Cerebral Blood Flow in Children with Obsessive Compulsive Disorder.
Rasim Somer DILER ; Mustafa KIBAR ; Ayse AVCI
Yonsei Medical Journal 2004;45(1):90-99
While regional cerebral blood flow (rCBF) studies on adults involving the caudate, prefrontal, orbitofrontal, and cingulated areas have been reported, no such published data on children exist. In this study, we aimed to determine the significance of pre- and post-treatment regional cerebral blood flow (rCBF) differences in children with obsessive compulsive disorder (OCD) and compared them with healthy controls. Eighteen drug-free obsessive compulsive children, aged 11 to 15, without comorbid states except for anxiety disorders - participated in this study. The control group consisted of 12 children, aged 11 to 15, with no medical or psychiatric illnesses. Using SPECT (Single Photon Emission Computerized Tomography) scans with Technetium-99m-HMPAO-hexamethly propyleneamine oxime (Tc99mHMPAO), the rCBF was calculated in 15 regions of the control group according to a standard protocol, while in the study group, it was measured at baseline and after 12 weeks of treatment with a fixed dose of paroxetine (20 mg qd). We compared the resulting pre- and post-treatment CBF values for the control group and study group. The right and left caudates, right and left dorsolateral prefrontals, and cingulate had significantly higher rCBF in children with obsessive compulsive disorder than in the control group. These areas, in addition to the right anteromedial temporal, showed significant rCBF reduction after treatment with paroxetine. The mean percentage of change in obsession scores during the treatment correlated significantly with the baseline and post- treatment rCBF level of the right caudate, post-treatment left caudate, and baseline left caudate. Our findings on children are consistent with adult studies and support the theory of a cortical-striatal-thalamic-cortical loop disturbance in OCD.
Adolescent
;
Cerebrovascular Circulation/*drug effects
;
Child
;
Depressive Disorder/drug therapy/physiopathology/radionuclide imaging
;
Female
;
Human
;
Male
;
Obsessive-Compulsive Disorder/*drug therapy/*physiopathology/radionuclide imaging
;
Paroxetine/*administration & dosage
;
Serotonin Uptake Inhibitors/*administration & dosage
;
Technetium Tc 99m Exametazime/diagnostic use
;
Tomography, Emission-Computed, Single-Photon